Skip to content

Gilead Sciences GILD Interest coverage

Interest coverage at other companies

Incyte logo
IncyteINCY
689.3×+620×
Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
ALN
Alnylam PharmaceuticalsALNY
3.4×+2.9×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
75.6×-4.5×
Agilent Technologies logo
Agilent TechnologiesA
14.8×+2.0×
Danaher logo
DanaherDHR
18.6×+1.7×

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$153.66B+23.8%
Enterprise value$168.2B+19.7%
P/E16.7×-4.1×
P/S5.2×+0.8×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Calculated from Gilead Sciences’s reported figures.

Based on trailing twelve months.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's interest coverage?
Gilead Sciences (GILD) reported interest coverage of 10.3× in Q1 2026.
How has Gilead Sciences's interest coverage changed year-over-year?
Gilead Sciences's interest coverage increased by 23.5% year-over-year, from 8.4× to 10.3×.
What is the long-term trend for Gilead Sciences's interest coverage?
Over 4 years (2021 to 2025), Gilead Sciences's interest coverage has grown at a 0.8% compound annual growth rate (CAGR), from 35.4× to 36.5×.
What does interest coverage mean?
How many times the company's operating profit covers its interest bill.
How do you interpret interest coverage?
Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
How does interest coverage compare across companies?
Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.